Related Experiment Videos
Kasabach merritt syndrome: management with interferon
Sandhya Acharya1, Kalyani Pillai, Abel Francis
1Department of Dermatology, Amala Institute of Medical Sciences,(AIMS), Thrissur, Kerala, India.
Indian Journal of Dermatology
|November 11, 2010
Summary
Kasabach Merritt Syndrome (KMS) treatment requires a stepwise approach. Interferon-alpha-2b effectively managed a severe case, increasing platelet counts and regressing the vascular tumor.
Area of Science:
- Pediatric Oncology
- Hematology
- Vascular Biology
Background:
- Kasabach Merritt Syndrome (KMS) is a rare, aggressive vascular tumor.
- KMS presents challenges in managing consumptive coagulopathy and tumor regression.
Purpose of the Study:
- To outline a stepwise management strategy for Kasabach Merritt Syndrome.
- To report the efficacy of Interferon-alpha-2b in treating a severe pediatric KMS case.
Main Methods:
- Initial management included platelet and plasma transfusions for coagulopathy.
- Systemic corticosteroids and attempted embolization showed no significant effect.
- Interferon-alpha-2b (IFN α 2b) was administered subcutaneously at 3 million IU/m²/day.
Main Results:
- IFN α 2b treatment led to increased platelet counts within one month.
- Significant regression of the vascular tumor was observed.
- The patient's coagulopathy resolved with tumor regression.
Conclusions:
- A stepwise approach is crucial for managing Kasabach Merritt Syndrome.
- Interferon-alpha-2b is an effective therapeutic option for recalcitrant KMS.
- Early intervention with appropriate therapies can improve outcomes in KMS patients.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...